The abstract is read at the publisher; the summary is JClub's.
Tumor-infiltrating regulatory T cells show a senescence-like state marked by elevated p16 and p21, SASP, and SA-beta-Gal while retaining immunosuppressive capacity.
- Why it matters: Immune suppression by tumor-infiltrating Treg cells limits anti-tumor immunity and the effectiveness of immune checkpoint inhibitors, but whether they acquire senescence-associated features is unclear.
- What they did: The study compared tumor-infiltrating versus peripheral Treg cells from solid cancers, measuring canonical senescence markers (p16, p21, DNA damage response, SASP, anti-apoptotic BCL-2 family genes) and SA-beta-Gal activity.
- The result: Despite apoptosis- and senescence-associated phenotypes, tumor-infiltrating Treg cells paradoxically maintain key immunosuppressive molecules, suggesting a senescence-associated reprogramming state that could be therapeutically targeted.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.